...
首页> 外文期刊>Experimental and therapeutic medicine >Effects of different doses of dexmedetomidine on analgesic efficacy and inflammatory cytokines in patients undergoing laparoscopic surgery
【24h】

Effects of different doses of dexmedetomidine on analgesic efficacy and inflammatory cytokines in patients undergoing laparoscopic surgery

机译:不同剂量的Dexmedetomidine对腹腔镜手术患者镇痛疗效和炎性细胞因子的影响

获取原文
获取原文并翻译 | 示例
           

摘要

The effects of different doses of dexmedetomidine on analgesic efficacy and inflammatory cytokines in patients with laparoscopic surgery were investigated. A total of 179 laparoscopic patients from March 2015 to May 2017 were enrolled and randomly divided into the control group (group A) and three experimental groups with different doses of dexmedetomidine (group B: 0.25; group C: 0.5 and group D: 1 mu g/kg). Results showed that there was no significant difference between the four groups in the operation time, the amount of surgical bleeding and intraoperative fluid infusion. The VAS score of group A was significantly higher than the other three groups. In addition, the VAS score of group D at each time-point was the lowest. There was no significant difference regarding the agitation score and sedation score between group A and group B. Furthermore, the restlessness score and sedation score in group C were significantly lower than those in group A and group B. Next we found that CRP and TNF- in group A and group B were significantly higher than those in groups C and D. In addition, IL-10 in group D was significantly higher than that in group C. Moreover, patients in group C had the least adverse reaction effects. In conclusion, medium dosage of dexmedetomidine cannot only effectively relieve the pain of laparoscopic patients but also regulate the secretion of inflammatory cytokines.
机译:研究了不同剂量的Dexmedetomidine对腹腔镜手术患者镇痛效果和炎性细胞因子的影响。从2015年3月至2017年5月共注册并随机分为对照组(A组)和三种实验组,共进行179名腹腔镜患者,具有不同剂量的右甲酰嘌呤(B:0.25; C组:0.5和D组:1亩g / kg)。结果表明,手术时间内四组之间没有显着差异,手术出血和术中液体输注的量。 A组的VAS得分明显高于其他三组。此外,每个时间点的D组VAS评分最低。关于A组和B组之间的搅拌得分和镇静评分没有显着差异。此外,C组中的不安分数和镇静评分明显低于A和B组中的胃肠分数。接下来我们发现CRP和TNF-在A组和B组中显着高于C和D组中的B.此外,D组IL-10显着高于C组中的IL-10。此外,C组患者具有最小的不良反应效果。总之,德克梅哌咪唑的中剂量不能有效地缓解腹腔镜患者的疼痛,而且还可以调节炎症细胞因子的分泌。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号